Chemotherapy-induced changes in serum vitamin B 12  binding proteins in myeloid leukemia.
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001215:Asparaginase / Q000494:pharmacology / Q000627:therapeutic use; D002066:Busulfan / Q000494:pharmacology / Q000627:therapeutic use; D002852:Chromatography, Ion Exchange; D003036:Cobalt Isotopes; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D007958:Leukocyte Count; D015122:Mercaptopurine / Q000494:pharmacology / Q000627:therapeutic use; D011485:Protein Binding / Q000187:drug effects*; D012712:Serum Globulins / Q000096:biosynthesis; D014805:Vitamin B 12 / Q000097:blood*
D000970:Antineoplastic Agents; D003036:Cobalt Isotopes; D012712:Serum Globulins; D003561:Cytarabine; D015122:Mercaptopurine; D001215:Asparaginase; D002066:Busulfan; D014805:Vitamin B 12